OPKO Health
OPK
$1.24
Share price
0.81%
Change (1 day)
-15.07%
Change (1 year)
Categories
OPKO Health (OPK) Fails to deliver data
Key failure to deliver metrics for OPKO Health :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $26.27 M
- Last 3 months FTD volume: $39.65 M
- Last year FTD volume: $43.26 M
Failures to deliver for OPKO Health (OPK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for OPKO Health (OPK) - since 2013
Volume in USD (price x number of shares), data since 2013OPKO Health (OPK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $39.65 M | 767.94% |
| 2023 | $4.56 M | -72.01% |
| 2022 | $16.32 M | -44.51% |
| 2021 | $29.41 M | -63.07% |
| 2020 | $79.64 M | 122.76% |
| 2019 | $35.75 M | -46% |
| 2018 | $66.21 M | -54.43% |
| 2017 | $0.14 B | -47.42% |
| 2016 | $0.27 B | 9.96% |
| 2015 | $0.25 B | -37.28% |
| 2014 | $0.40 B | 16.96% |
| 2013 | $0.34 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $62.08 M | $0.14 B | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $59.04 M | $0.14 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 LabCorp LH | $18.16 M | $53.7 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.22 M | $43.68 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | 🇮🇱 Israel |
 Ardelyx ARDX | $8.97 M | $30.7 M | 🇺🇸 USA |